Clinical trial
NOBORI Biolimus-Eluting Versus XIENCE/PROMUS Everolimus-eluting Stent Trial
NCT01303640 is registered in ClinicalTrials.gov with Takeshi Morimoto as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- NOBORI Biolimus-Eluting Versus XIENCE/PROMUS Everolimus-eluting Stent Trial
- Lead sponsor
- Takeshi Morimoto
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- May 31, 2011
- Completion date
- October 31, 2015
- Enrollment
- 3,235 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.